Mireia is member of the Board of Directors of NuMat Medtech.
Mireia holds a PhD in Genetics from University of Barcelona and earned her MBA from EADA business school.
Mireia was an Investment Analyst at Healthequity and worked for the technology transfer office of the University of Barcelona and the Clinical Hospital of Barcelona.
Currently, Mireia is an Investment Manager in Caixa Capital Risc. She focuses on the Life sciences sector, leading investments in companies developing therapeutics, diagnostic products and medical devices.